Regorafenib, nivolumab, chemo combo found safe and effective for various cancers, heading to phase 3 trial
Researchers at Memorial Sloan Kettering Cancer Center, New York, have concluded their phase 2 trial of chemotherapy in combination with the drugs nivolumab, and regorafenib.
